Skip to content
thumbnail_image002

Yesterday, we launched a new suite of online events: The Deskside Series. Designed to give you access to some of the best and brightest minds at Stanford University School of Medicine, these 45-minute sessions will feature a moderated presentation and Q&A. In our inaugural Deskside, I sat down (virtually) with Bonnie Halpern-Felsher, PhD to discuss COVID-19, vaping, and teens.

We know for a fact that vaping is risky to developing brains. We know it correlates with future cigarette and drug use. And yet, vaping among teens is still on the rise. More than 1 in 4 high school students use e-cigarettes. That's almost three times as many as just two years ago. COVID-19 is raising the stakes for vaping, but we have a plan to wipe it out.

During the Deskside, we introduced 17-year-old Luka from North Carolina. I can’t stop thinking about his story—being offered an e-cigarette and being told it was just vegetable oil and water. It drives home how vital Dr. Bonnie Halpern-Felsher’s research and anti-vaping advocacy work are for young people in our community and beyond. The impact we make today can save teens’ lives, especially as we face COVID-19 and the added risks for vape users. Are you ready to dive in?

  • Watch and share the webinar recording.

​

Thank you again for joining us as we embark on this new Deskside series, learning together how we can ensure our children and young people have healthier futures.